Pirenperone: Difference between revisions

Latest revision as of 04:00, 13 February 2025

Overview[edit]

Pirenperone is a chemical compound that acts as a selective antagonist of the serotonin 5-HT2A receptor. It is primarily used in research settings to study the role of serotonin receptors in various physiological and psychological processes.

Chemical Structure[edit]

Pirenperone is a member of the butyrophenone class of compounds, which are known for their antipsychotic and neuroleptic properties. The chemical structure of pirenperone includes a butyrophenone backbone with a piperidine ring, which is characteristic of this class of drugs.

Mechanism of Action[edit]

Pirenperone functions by binding to the 5-HT2A receptor, a subtype of the serotonin receptor family. By blocking these receptors, pirenperone can modulate the effects of serotonin in the brain, which is important for understanding the role of serotonin in mood regulation, perception, and cognition.

Research Applications[edit]

Pirenperone is used extensively in neuroscience research to investigate the effects of serotonin receptor antagonism. It has been utilized in studies exploring the pathophysiology of schizophrenia, depression, and other psychiatric disorders. Additionally, pirenperone is used in animal models to study the effects of serotonin on behavior and brain function.

Pharmacological Properties[edit]

Pirenperone is known for its high affinity for the 5-HT2A receptor, making it a valuable tool in research. It has a relatively low affinity for other serotonin receptor subtypes, which allows for more selective studies of 5-HT2A-mediated processes.

Safety and Toxicology[edit]

As a research chemical, pirenperone is not approved for clinical use in humans. Its safety profile is primarily characterized in preclinical studies, where it is generally well-tolerated at doses used in research settings. However, detailed toxicological data in humans is limited.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-'''Pirenperone''' is an [[antipsychotic]] drug that was developed in the 1970s. It is classified as an [[atypical antipsychotic]] due to its unique pharmacological properties. Pirenperone has been studied for its potential use in the treatment of [[schizophrenia]], but it has not been widely adopted in clinical practice.
+{{DISPLAYTITLE:Pirenperone}}
-==Pharmacology==
+== Overview ==
-Pirenperone acts as an antagonist at the [[Dopamine receptor D2|D2 dopamine receptor]] and the [[Serotonin receptor 5-HT2A|5-HT2A serotonin receptor]], which are both implicated in the pathophysiology of schizophrenia. It also has affinity for the [[Histamine receptor H1|H1 histamine receptor]] and the [[Alpha-1 adrenergic receptor|alpha-1 adrenergic receptor]], which may contribute to its side effect profile.
+'''Pirenperone''' is a chemical compound that acts as a selective antagonist of the [[serotonin]] 5-HT2A receptor. It is primarily used in research settings to study the role of serotonin receptors in various physiological and psychological processes.
-==Clinical Use==
+== Chemical Structure ==
-While pirenperone has been studied in clinical trials for the treatment of schizophrenia, it has not been widely adopted in clinical practice. The reasons for this are not entirely clear, but may relate to its side effect profile or lack of clear superiority over other available antipsychotic drugs.
+[[File:Pirenperone.svg|thumb|right|Chemical structure of Pirenperone]]
+Pirenperone is a member of the butyrophenone class of compounds, which are known for their antipsychotic and neuroleptic properties. The chemical structure of pirenperone includes a butyrophenone backbone with a piperidine ring, which is characteristic of this class of drugs.
-==Side Effects==
+== Mechanism of Action ==
-Like many antipsychotic drugs, pirenperone can cause a range of side effects. These may include [[sedation]], [[orthostatic hypotension]], and [[anticholinergic]] effects such as dry mouth and constipation. It may also cause [[extrapyramidal symptoms]] such as tremor and rigidity, although these are generally less common with atypical antipsychotics like pirenperone than with older, typical antipsychotics.
+Pirenperone functions by binding to the 5-HT2A receptor, a subtype of the [[serotonin receptor]] family. By blocking these receptors, pirenperone can modulate the effects of serotonin in the brain, which is important for understanding the role of serotonin in mood regulation, perception, and cognition.
-==See Also==
+== Research Applications ==
-* [[Atypical antipsychotic]]
+Pirenperone is used extensively in [[neuroscience]] research to investigate the effects of serotonin receptor antagonism. It has been utilized in studies exploring the pathophysiology of [[schizophrenia]], [[depression]], and other psychiatric disorders. Additionally, pirenperone is used in animal models to study the effects of serotonin on behavior and brain function.
-* [[Dopamine receptor D2]]
-* [[Serotonin receptor 5-HT2A]]
-* [[Histamine receptor H1]]
-* [[Alpha-1 adrenergic receptor]]
-[[Category:Antipsychotics]]
+== Pharmacological Properties ==
-[[Category:Atypical antipsychotics]]
+Pirenperone is known for its high affinity for the 5-HT2A receptor, making it a valuable tool in research. It has a relatively low affinity for other serotonin receptor subtypes, which allows for more selective studies of 5-HT2A-mediated processes.
-[[Category:Pharmacology]]
-[[Category:Medicine]]
-{{stub}}
+== Safety and Toxicology ==
+As a research chemical, pirenperone is not approved for clinical use in humans. Its safety profile is primarily characterized in preclinical studies, where it is generally well-tolerated at doses used in research settings. However, detailed toxicological data in humans is limited.
+== Related Pages ==
+* [[Serotonin receptor]]
+* [[5-HT2A receptor]]
+* [[Antipsychotic]]
+* [[Neurotransmitter]]
+[[Category:Serotonin receptor antagonists]]
+[[Category:Research chemicals]]